Jian‐Chuan Xia

9.9k total citations · 1 hit paper
164 papers, 5.2k citations indexed

About

Jian‐Chuan Xia is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jian‐Chuan Xia has authored 164 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 84 papers in Immunology and 45 papers in Molecular Biology. Recurrent topics in Jian‐Chuan Xia's work include Immune Cell Function and Interaction (48 papers), Cancer Immunotherapy and Biomarkers (47 papers) and Immunotherapy and Immune Responses (40 papers). Jian‐Chuan Xia is often cited by papers focused on Immune Cell Function and Interaction (48 papers), Cancer Immunotherapy and Biomarkers (47 papers) and Immunotherapy and Immune Responses (40 papers). Jian‐Chuan Xia collaborates with scholars based in China, United States and Hong Kong. Jian‐Chuan Xia's co-authors include De-Sheng Weng, Jing-Jing Zhao, Ke Pan, Yong-Qiang Li, Qiu-Zhong Pan, Qi-Jing Wang, Xiao Hai Li, Jia He, Shan-Shan Jiang and Ke Pan and has published in prestigious journals such as Circulation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jian‐Chuan Xia

158 papers receiving 5.1k citations

Hit Papers

Functional Mesenchymal St... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Chuan Xia China 42 2.4k 2.3k 1.7k 633 608 164 5.2k
Bo Tang China 31 2.4k 1.0× 1.9k 0.8× 2.5k 1.5× 628 1.0× 828 1.4× 114 6.5k
G. Kenneth Haines United States 43 2.2k 0.9× 2.3k 1.0× 2.1k 1.2× 683 1.1× 702 1.2× 92 6.6k
Serge Haan Germany 24 2.7k 1.1× 1.8k 0.8× 1.7k 1.0× 300 0.5× 676 1.1× 36 4.8k
Matthias Friedrich Germany 31 1.6k 0.7× 1.5k 0.6× 1.7k 1.0× 439 0.7× 547 0.9× 72 4.6k
Hiroaki Niiro Japan 43 843 0.4× 2.8k 1.2× 1.3k 0.8× 373 0.6× 352 0.6× 145 5.4k
Yoshihisa Nojima Japan 40 844 0.4× 1.6k 0.7× 2.2k 1.3× 772 1.2× 362 0.6× 231 6.1k
Dimitrios Mougiakakos Germany 41 2.6k 1.1× 3.0k 1.3× 2.6k 1.5× 532 0.8× 920 1.5× 144 7.0k
Rory R. Koenen Netherlands 42 1.4k 0.6× 3.6k 1.6× 2.4k 1.4× 558 0.9× 927 1.5× 108 7.0k
Sònia Tugues Switzerland 25 1.1k 0.4× 1.5k 0.7× 1.2k 0.7× 413 0.7× 334 0.5× 40 3.6k
Zongbing You United States 35 1.5k 0.6× 1.5k 0.7× 1.7k 1.0× 446 0.7× 607 1.0× 87 4.3k

Countries citing papers authored by Jian‐Chuan Xia

Since Specialization
Citations

This map shows the geographic impact of Jian‐Chuan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Chuan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Chuan Xia more than expected).

Fields of papers citing papers by Jian‐Chuan Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Chuan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Chuan Xia. The network helps show where Jian‐Chuan Xia may publish in the future.

Co-authorship network of co-authors of Jian‐Chuan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Chuan Xia. A scholar is included among the top collaborators of Jian‐Chuan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Chuan Xia. Jian‐Chuan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yan, Yuanyuan Chen, Jingjing Zhao, et al.. (2025). Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-κB and STAT3 signaling pathways in nasopharyngeal carcinoma. Cell Death and Disease. 16(1). 129–129. 6 indexed citations
2.
Li, Tiantian, Yueyi Chen, Shi Gu, et al.. (2025). Effect of whey protein isolate on the quality of rice bread. Journal of Cereal Science. 126. 104290–104290.
3.
Chen, Yuanyuan, Yan Tang, Jingjing Zhao, et al.. (2024). Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene. 43(28). 2143–2159. 5 indexed citations
4.
Liu, Bing, Qiuzhong Pan, Meixiao Zhan, et al.. (2024). SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular Cancer Therapeutics. 23(8). 1188–1200. 1 indexed citations
5.
Duan, Hao, Zhenqiang He, Yukun Chen, et al.. (2024). Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. BMC Immunology. 25(1). 83–83.
6.
Song, Mengjia, Shaoyan Cheng, Yaojun Zhang, et al.. (2024). DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma. Cancer Research. 84(10). 1613–1629. 19 indexed citations
8.
Xia, Jian‐Chuan, et al.. (2023). Relationship between insulin-like growth factor-1 and cerebral small vessel disease and its mechanisms: advances in the field. Frontiers in Aging Neuroscience. 15. 1190869–1190869. 6 indexed citations
9.
Song, Mengjia, Ping Yü, Kai Zhang, et al.. (2019). Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer. Cancer Research. 79(14). 3737–3748. 113 indexed citations
10.
Pan, Ke, Yong-Qiang Li, Jing-Jing Zhao, et al.. (2014). Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research. 20(11). 3003–3011. 77 indexed citations
11.
Lü, Lin, Ke Pan, Haixia Zheng, et al.. (2013). IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival. Journal of Immunotherapy. 36(8). 451–458. 77 indexed citations
12.
Zhang, Xuan, Xuan Zhang, Xiaona You, et al.. (2012). Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA. FEBS Letters. 586(19). 3215–3221. 13 indexed citations
13.
Xia, Jian‐Chuan, Ke Pan, Wei Wang, et al.. (2011). Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients. International Journal of Biological Sciences. 7(1). 53–60. 90 indexed citations
14.
Pan, Ke, Min-Shan Chen, Qi-Jing Wang, et al.. (2010). Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells. Cancer Biology & Therapy. 10(4). 368–375. 34 indexed citations
15.
Pan, Ke, MinShan Chen, Jianjun Li, et al.. (2010). Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26(3). 544–549. 22 indexed citations
17.
Jaskelioff, Mariela, Jian‐Chuan Xia, C Liu, et al.. (2009). Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene. 28(48). 4225–4236. 18 indexed citations
18.
Liu, Ji-yan, Yang Wu, Xiao-Shi Zhang, et al.. (2007). Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine. Cancer Immunology Immunotherapy. 56(10). 1597–1604. 106 indexed citations
19.
Xia, Jian‐Chuan, et al.. (2007). [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].. PubMed. 26(2). 137–41. 2 indexed citations
20.
Chen, Dongshu, Jian‐Chuan Xia, Yasuhiro Tanaka, et al.. (2003). Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1‐positive carcinoma cells. Immunology. 109(2). 300–307. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026